Normal Absolute Monocyte Count in Combination with Normal/High Absolute Lymphocyte Count at the Time of Relapse is Associated with Improved Survival in Patients with Early Relapsed Acute Myeloid Leukemia-Reference-Cited by-同舟云学术

Normal Absolute Monocyte Count in Combination with Normal/High Absolute Lymphocyte Count at the Time of Relapse is Associated with Improved Survival in Patients with Early Relapsed Acute Myeloid Leukemia

Published:2021-06-09 Issue:6-7 Volume:39 Page:550-558
ISSN:0735-7907
Container-title:Cancer Investigation
language:en
Short-container-title:Cancer Investigation

Author:

Zhang Yu¹,Dai Kanchun²,Zhang Qianying¹,Huang Yisha¹,Feng Yiyun¹,Bhardwaj Deeksha¹,Yu Kang¹,Feng Jianhua¹³

Affiliation:

1. Department of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, PR China

2. Department of Hematology and Oncology, Hwa Mei Hospital, University of Chinese Academy of Sciences (Ningbo NO. 2 Hospital), Ningbo, PR China

3. Department of Pediatric Hematology-Oncology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, PR China

Funder

Natural Science Foundation of Zhejiang Province

Public Welfare Science and Technology Project of Wenzhou

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/07357907.2021.1933013

Reference40 articles.

1. Sequential multiagent chemotherapy is not superior to high-dose cytarabine alone as postremission intensification therapy for acute myeloid leukemia in adults under 60 years of age: Cancer and Leukemia Group B Study 9222

2. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study

3. A phase 3 study of three induction regimens and of priming with GM-CSF in older adults with acute myeloid leukemia: a trial by the Eastern Cooperative Oncology Group

4. Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trial

5. Acute Myeloid Leukemia

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CSRP1 gene: a potential novel prognostic marker in acute myeloid leukemia with implications for immune response;Discover Oncology;2024-06-27

2. White blood cell count nadir to zero following intensive chemotherapy as a predictive factor for patients with acute myeloid leukemia;Leukemia & Lymphoma;2024-03-03

3. Pretreatment total lymphocyte count as a prognostic factor of survival in patients with recurrent cervical cancer after definitive radiation-based therapy: a retrospective study;Obstetrics & Gynecology Science;2023-09-15